|
Treatment
|
|---|
| |
Total (%)
|
Group 1 (PICU) (%)
|
Group 2 (non-PICU) (%)
|
p values
|
|---|
|
Total
|
26
|
15
|
11
|
|---|
|
Inotropesa
|
12 (46.2)
|
12 (80)
|
0 (0)
|
0.0001*
|
|
Aspirin
|
25 (96.2)
|
15 (100)
|
10 (90.9)
|
0.4231
|
|
Low-molecular weight heparin
|
12 (46.2)
|
9 (60)
|
3 (27.3)
|
0.0982
|
|
Heparin
|
5 (19.2)
|
5 (33.3)
|
0 (0)
|
0.0527
|
|
IVIG
|
25 (96.2)
|
15 (100)
|
10 (90.9)
|
0.4231
|
|
Steroids
|
22 (84.6)
|
13 (86.7)
|
9 (81.8)
|
1.0
|
|
Steroid pulse
|
7 (26.9)
|
6 (40)
|
1 (9.1)
|
0.1783
|
|
Anakinra
|
13 (50)
|
10 (66.7)
|
3 (27.3)
|
0.0472*
|
|
Infliximab
|
1 (3.9)
|
1 (6.7)
|
0 (0)
|
1.0
|
- IVIG Intravenous immune globulin
- aThis included epinephrine, norepinephrine, vasopressin, and/or milrinone
- *significant p value (≤0.05)
